Do Young Kim, Hong Jeoung Kim, C. Lee
Feb 1, 2007
Citations
0
Influential Citations
15
Citations
Quality indicators
Journal
Liver International
Abstract
Background and Aims: Adefovir dipivoxil (ADV) is a nucleotide analogue that is known to be effective for lamivudine‐resistant hepatitis B virus (HBV) mutants as well as wild‐type HBV. The aim of this study is to assess the efficacy of ADV against lamivudine‐resistant genotype C HBV mutants.